CL-870801

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCL-870801
Drug Alias NameCL-870801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsSerotonin 1a (5-HT1a) receptor agonists
TargetsAdrenergic receptors alpha-1Serotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGe Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGe Healthcare
Active IndicationsN/A
Inactive IndicationsHypertensionHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A